Metraipolis › archive › dc_cd31d80f0de8
Hydroxysafflor Yellow A improves diabetic nephropathy by inhibiting PI3K/AKT/mTOR pathway based on a multidimensional study — Europe PMC PMID:41704706
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41704706
- DOI
- 10.3389/fmed.2026.1747346
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T04:34:17.672Z
- SHA-256 of the archived text
445a1b6e01b801c23d1eee75e99ef8e2900a1fe021290c5b654625665049012e- Stable URL of this page
https://metraipolis.com/documento/dc_cd31d80f0de8
How to cite
Hydroxysafflor Yellow A improves diabetic nephropathy by inhibiting PI3K/AKT/mTOR pathway based on a multidimensional study — Europe PMC PMID:41704706 — Europe PMC (en), https://europepmc.org/article/MED/41704706 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd31d80f0de8 (Metraipolis archive dc_cd31d80f0de8, sha256 445a1b6e01b801c23d1eee75e99ef8e2900a1fe021290c5b654625665049012e)
BibTeX
@misc{dccd31d80f0de8,
title = {Hydroxysafflor Yellow A improves diabetic nephropathy by inhibiting PI3K/AKT/mTOR pathway based on a multidimensional study — Europe PMC PMID:41704706},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41704706},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd31d80f0de8; sha256 445a1b6e01b801c23d1eee75e99ef8e2900a1fe021290c5b654625665049012e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41704706. Agents can read the archived copy with the MCP tool read_document.